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Background: Alcohol consumption and related harm increase steeply from the ages of 12–20 years.
Adolescents in the UK are among the heaviest drinkers in Europe. Excessive drinking in adolescents is
associated with increased risk of accidents, injuries, self-harm, unprotected or regretted sex, violence and
disorder, poisoning and accidental death. However, there is lack of clear evidence for the most clinically
effective and cost-effective screening and brief interventions for reducing or preventing alcohol
consumption in adolescents attending emergency departments (EDs).
Objectives: To estimate the distribution of alcohol consumption, alcohol-related problems and alcohol use
disorders in adolescents attending EDs; to develop age-appropriate alcohol screening and brief intervention
tools; and to evaluate the clinical effectiveness and cost-effectiveness of these interventions.
Design: The research has been conducted in three linked stages: (1) a prevalence study, (2) intervention
development and (3) two linked randomised controlled trials (RCTs).
Setting: Twelve EDs in England (London, North East, and Yorkshire and The Humber).
Participants: A total of 5376 participants in the prevalence study [mean age 13.0 years, standard
deviation (SD) 2.0 years; 46.2% female] and 1640 participants in the two linked RCTs (mean age
15.6 years, SD 1.0 years; 50.7% female).
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Interventions: Personalised feedback and brief advice (PFBA) and personalised feedback plus electronic
brief intervention (eBI), compared with alcohol screening alone. These age-appropriate alcohol
interventions were developed in collaboration with the target audience through a series of focus groups
and evaluations during stage 2 of the research programme and following two literature reviews.
Main outcome measures: Total alcohol consumed in standard UK units (1 unit = 8 g of ethanol) over the
previous 3 months at 12-month follow-up, assessed using the Alcohol Use Disorders Identification Test,
Consumption (3 items) (AUDIT-C).
Results: In the prevalence study, 2112 participants (39.5%) reported having had a drink of alcohol that
was more than a sip in their lifetime, with prevalence increasing steadily with age and reaching 89.5% at
the age of 17 years. The prevalence of at-risk alcohol consumption was 15% [95% confidence interval (CI)
14% to 16%] and the optimum cut-off point of the AUDIT-C in identifying at-risk drinking was ≥ 3.
Associations of alcohol consumption and early onset of drinking with poorer health and social functioning
were also found. In the RCT, the analysis of the primary outcome (average weekly alcohol consumption at
month 12) identified no significant differences in effect between the three groups in both trials. In the
high-risk drinking trial, the mean difference compared with control was 0.57 (95% CI –0.36 to 1.70)
for PFBA and 0.19 (95% CI –0.71 to 1.30) for eBI. In the low-risk drinking trial, the mean difference
compared with control was 0.03 (95% CI –0.07 to 0.13) for PFBA and 0.01 (95% CI –0.10 to 0.11) for eBI.
The health economic analysis showed that eBI and PFBA were not more cost-effective than screening alone.
Conclusions: The ED can offer an opportunity for the identification of at-risk alcohol use in adolescents.
A simple, short, self-completed screening instrument, the AUDIT-C, is an effective tool for identifying
adolescents who are at risk of alcohol-related problems. Associations of alcohol consumption and earlier
onset of drinking with poorer health and social functioning were observed in the prevalence study.
The trials were feasible to implement and exceeded the recruitment target and minimum follow-up rates.
However, PFBA and eBI were not found to be more effective than screening alone in reducing or
preventing alcohol consumption in 14- to 17-year-olds attending EDs.
Limitations and future work: Only one-third of participants engaged with the application program; this
is likely to have limited the effect of the intervention. We recommend that future research should focus on
methods to maximise engagement with digital interventions and evaluate the effect of such engagement
on clinical outcomes.
Trial registration: Current Controlled Trials ISRCTN45300218.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 8, No. 2. See the NIHR Journals Library website for further project information.
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Adolescents in the UK are among the heaviest-drinking adolescents in Europe. Drinking in adolescenceis associated with alcohol-related harms, and early drinking is linked to intellectual impairment and
more serious alcohol problems later on in life.
This research was conducted in three stages and targeted adolescents presenting to emergency
departments to identify the size of the problem and develop and evaluate age-appropriate interventions.
First, we surveyed 5000 adolescents attending emergency departments, 40% of whom had drunk more
than a sip of alcohol in their lifetime. Drinking earlier was linked to poorer health, and to alcohol and social
problems. We found that a short questionnaire can identify adolescents who are drinking at risky levels.
Second, we reviewed published research and developed interventions. We met adolescents and parents to
design the third stage of our research.
We then did two studies: (1) a study among adolescents drinking little who were aiming to delay starting
drinking and (2) a study among adolescents drinking more who were aiming to reduce their consumption.
Participants were allocated to one of three groups by chance: (1) screening only and care as usual,
(2) feedback and brief alcohol advice, and (3) feedback and an application program with alcohol advice.
We successfully ran both studies and exceeded targets for recruitment and follow-up. However, we found
that neither of our interventions was effective in reducing alcohol consumption in adolescents drinking
high quantities of alcohol, or in delaying drinking in those drinking less or not drinking, compared with
screening alone. Moreover, these interventions did not represent value for money compared with
screening alone.
We later interviewed adolescents in the studies to explore their understanding and experience of taking
part. Adolescents felt that they should know more about the risks of alcohol, that the advice was helpful
and that emergency departments were a useful setting.
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Alcohol consumption is a major public health concern. Although the main burden of chronic alcohol-
related disease is in adults, its foundations often lie in adolescence. Alcohol consumption and related harm
increase steeply from the age of 12 years, and although the proportion of young people in England aged
between 11 and 15 years who reported that they had drunk alcohol had decreased in the last 30 years,
the mean amount consumed by those who drank doubled. About 10% of 11- to 15-year-olds and 33% of
15- to 16-year-olds in England had reported alcohol intoxication in the past month.
Alcohol use and alcohol use disorders (AUDs) are relatively uncommon in early adolescence. Nevertheless,
alcohol has a disproportionate effect on younger adolescents, for example by predisposing them to alcohol
dependence in later life and damage to the developing brain. In middle adolescence (ages 15–17 years),
binge drinking emerges. Although binge drinking does not necessarily meet the criteria for an AUD, it is
associated with an increased risk of unprotected or regretted sexual activity, criminal and disorderly
behaviour, suicidality and self-harm, injury, drink driving, alcohol poisoning and accidental death.
In 2009, the Chief Medical Officer for England provided recommendations on alcohol consumption in young
people based on an evidence review (Donaldson L. Guidance on the Consumption of Alcohol by Children
and Young People. London: Department of Health and Social Care; 2009). These recommendations stated
that children should abstain from alcohol before the age of 15 years and that 15- to 17-year-olds should not
drink, but, if they do drink, then they should consume no more than the recommended limits for adults
(currently 14 units per week).
Alcohol screening and brief interventions in health settings
Opportunistic alcohol screening and brief interventions (SBIs) in emergency departments (EDs) capitalise on
the ‘teachable moment’ when a connection can be made between alcohol consumption and ED attendance.
SBIs in EDs have shown efficacy in adults and adolescents, and evidence of cost-effectiveness in adults.
However, although there has been an increase in SBIs for adults, adolescents remain a comparatively
neglected group.
Several alcohol screening methods have been developed in the USA but not evaluated in the UK.
Questionnaires were found to perform better than blood markers or breath alcohol concentration in all
age groups. However, most of these had low sensitivity and specificity and are therefore suboptimal for
effective screening.
The validity of alcohol screening methods in younger adolescents is also unclear. Existing approaches do
not sufficiently take account of the age and developmental stage of adolescents.
Moreover, a systematic review of brief alcohol interventions in young people attending health settings
identified nine randomised controlled trials (RCTs) between 1999 and 2008. Eight were based in the USA
and one was based in Australia. Six trials tested brief interventions based on one or two sessions of
motivational interviewing (MI) that lasted between 20 and 45 minutes. One trial tested a more intensive
programme of four MI sessions over 1 month. Two studies used information technology to deliver brief
interventions, one using an audio programme in primary care and the other using an interactive computer
program in a minor injury unit.
DOI: 10.3310/pgfar08020 PROGRAMME GRANTS FOR APPLIED RESEARCH 2020 VOL. 8 NO. 2
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Deluca et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xix
Five trials reported significant positive effects of brief interventions on a range of alcohol consumption
measures, whereas three trials reported null effects after brief interventions. One trial reported an increase
in alcohol use and binge drinking among brief intervention subjects, which is a possible adverse effect.
Therefore, there is a need to develop more effective alcohol screening tools and interventions for
adolescents in the ED that are age appropriate and cover a wider range of alcohol consumption and
alcohol-related problems than do existing methods. Although evidence suggests that brief interventions
may be beneficial for adolescents, particularly in EDs, there is a clear need for a UK trial to examine this
further.
This research programme was designed to address these key gaps in the evidence base for the most
clinically effective and cost-effective SBIs for at-risk adolescent heavy drinkers, and prevent alcohol uptake
or increased alcohol consumption in low-risk adolescents attending EDs.
Work package 1: prevalence study of alcohol consumption and
alcohol use disorders in adolescents aged 10–17 years attending
emergency departments
This work package investigated the prevalence of alcohol consumption in adolescents presenting to EDs
and the association between that consumption, age at onset, and health and social behaviours. In
addition, we assessed the diagnostic performance of brief screening tools.
Methods
We included 5376 consecutive attenders, aged 10–17 years, at 10 EDs. We collected information on
alcohol use, alcohol-related health and social consequences, general health and social functioning, and
quality of life.
Results
Nearly 40% of adolescents reported that their consumption of alcohol was more than a sip in their
lifetime. First alcohol consumption before the age of 15 years was associated with tobacco use [odds ratio
(OR) 2.8, 95% confidence interval (CI) 1.8 to 4.2; p < 0.001], lower quality of life (OR 1.5, 95% CI 0.5 to
2.6; p = 0.003) and diagnosis of AUD (OR 2.4, 95% CI 1.3 to 4.4; p = 0.002). It was also associated with
impaired general social functioning [presence of conduct disorder (OR 4.5, 95% CI 1.8 to 11.4; p < 0.001)
and hyperactivity (OR 2.6, 95% CI 1.4 to 4.8; p < 0.001)], alcohol-related health and social consequences
[accidents (OR 1.8, 95% CI 1.0 to 3.2; p = 0.046), and problems with parents (OR 4.4, 95% CI 1.3 to 15.4;
p = 0.017), school (OR 3.7, 95% CI 1.2 to 11.3; p = 0.0117) or police (OR 13.5, 95% CI 1.7 to 102.4;
p = 0.012)].
We tested the screening properties of the questionnaire against the standard (Timeline Followback) criteria
for at-risk drinking, heavy episodic alcohol consumption and the International Classification of Diseases,
Tenth Edition (ICD-10), for hazardous alcohol use and dependence. We identified appropriate cut-off
points for each instrument. An Alcohol Use Disorders Identification Test, Consumption (3 items) (AUDIT-C)
score of ≥ 3 was the optimal cut-off point for at-risk drinking (sensitivity 0.89, 95% CI 0.89 to 0.91;
specificity 0.97, 95% CI 0.96 to 0.97), monthly episodic alcohol use (sensitivity 0.76, 95% CI 0.73 to 0.80;
specificity 0.98, 95% CI 0.97 to 0.98) and alcohol abuse (sensitivity 0.91, 95% CI 0.85 to 0.95; specificity
0.90, 95% CI 0.88 to 0.91). A score of 7 for the full Alcohol Use Disorders Identification Test was
considered the optimal cut-off point for identifying alcohol dependence (sensitivity 0.96, 95% CI 0.89 to
0.99; specificity 0.90, 95% CI 0.88 to 0.91).
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Conclusions
We found associations of alcohol consumption and earlier onset of drinking with poorer health and
social functioning. EDs offer opportunities to identify at-risk alcohol use in adolescents. A simple, short,
self-completed screening instrument, the AUDIT-C, is an effective tool for identifying adolescents who are
at risk of alcohol-related problems, or engage in monthly heavy episodic alcohol use or in harmful alcohol
use, according to the ICD-10 criteria. A score of 7 on the AUDIT-C is effective in identifying adolescents
who are alcohol dependent.
Work package 2: exploratory modelling of the interventions
This work package developed age-appropriate alcohol interventions in collaboration with the target
audience through a series of focus groups and evaluations.
Personalised feedback and brief advice
The personalised feedback and brief advice (PFBA) intervention is structured brief advice that takes
approximately 5 minutes to deliver. It is based on an advice leaflet from Screening and Intervention to
Promote Sensible drinking (SIPS), Brief Advice About Alcohol Risk, and was adapted for the target age
group in this study. The advice covers recommended levels of alcohol consumption for young people;
summarises the screening test results and their meaning; provides normative comparative information on
prevalence rates of high- and low-risk drinking in young people; summarises the risks of drinking and
highlights the benefits of stopping or reducing alcohol consumption; outlines strategies that the young
person might employ to help stop or reduce alcohol consumption; and indicates where to obtain further
help if they are unsuccessful or need more support.
Electronic brief intervention based on smartphone or web
The electronic brief intervention (eBI) smartphone intervention is an offline-capable mobile web application
that works on a variety of platforms, but it was optimised for recent iPhone (Apple Inc., Cupertino, CA, USA)
and Android (Google Inc., Mountain View, CA, USA) phones. It has been developed using the concept
of gamification so that users can navigate, explore, learn facts and figures about alcohol, receive personalised
feedback and set goals in an engaging format. The content adapts to provide the most pertinent information
and advice for high- or low-risk drinkers. Game components of the web application supported high-risk drinkers
to reduce or stop their alcohol consumption and low-risk users to maintain abstinence or low-risk drinking.
Work package 3: linked randomised controlled trials of face-to-face and
electronic brief intervention methods to prevent alcohol-related harm in
young people aged 14–17 years presenting to emergency departments
In work package 3, we conducted two linked RCTs to evaluate the clinical effectiveness and cost-effectiveness
of PFBA and eBI (the two alcohol interventions described above), compared with screening alone, in 14- to
17-year-olds attending 10 EDs in England. One trial focused on at-risk adolescent drinkers (AUDIT-C score
of ≥ 3) and the other focused on abstinent or low-risk drinkers (AUDIT-C score of < 3). Our primary (null)
hypothesis was similar for both trials: PFBA and personalised feedback plus eBI are as effective as screening
alone in reducing or preventing alcohol consumption, in standard UK units (1 unit = 8 g of ethanol), over
the past 3 months, at 12 months after randomisation, as measured with the AUDIT-C. Our secondary (null)
hypothesis for related health economics states that PFBA and eBI are as cost-effective as screening alone.
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Methods
We undertook participant recruitment, baseline data collection, randomisation, intervention delivery and
follow-up electronically via an ad hoc, secure computer tablet application developed as part of this
programme. We recruited 1639 participants into the trials from 10 EDs: 756 high-risk drinkers and 883
low-risk drinkers or abstainers. Follow-up at 6 and 12 months was 82.9% and 73.0%, respectively.
Results
The mean age of participants was 16.1 [standard deviation (SD) 0.9] years in the high-risk study and 15.2
(SD 1.0) years in the low-risk study. There was a similar proportion of male and female participants, with
50.7% female overall. Primary analysis employed an intention-to-treat approach, in which participants
were allocated as members of their allocated group irrespective of the treatment received. Analysis of the
primary outcome, namely average weekly alcohol consumption in standard UK units (1 unit = 8 g of ethanol)
at month 12, was conducted using analysis of covariance, adjusting for baseline values, age and gender.
There were no significant differences between the three groups in either trial: in the high-risk trial, the
mean difference compared with control was 0.57 (95% CI –0.36 to 1.70) for PFBA and 0.19 (95% CI
–0.71 to 1.30) for eBI; in the low risk trial, the mean difference compared with control was 0.03 (95% CI
–0.07 to 0.13) for PFBA and 0.01 (95% CI –0.10 to 0.11) for eBI. No significant interactions were observed
between baseline alcohol consumption and allocated intervention. Alcohol consumption at 12 months
was predicted at baseline by higher alcohol consumption, younger age at first drink, older age, being
female, greater positive alcohol expectancy and greater alcohol-related problems. Health economic
analysis supported the null hypothesis that neither PFBA nor eBI is more cost-effective than screening
alone in both trials.
Conclusions
Findings from this research indicate that both face-to-face and electronic interventions were neither more
effective nor more cost-effective than screening alone in reducing or preventing alcohol consumption in
14- to 17-year-olds attending EDs.
Qualitative study
Once follow-up was completed for all trials, we interviewed a sample of participating adolescents to
explore their understanding of the study, as well as their views about the information and advice
they received.
Methods
We interviewed 27 adolescents aged 14–17 years. Audio-recorded interviews were transcribed verbatim
and thematically analysed, guided by four ethical principles (autonomy, beneficence, non-maleficence
and justice).
Results
Participants were broadly positive about their experience of being approached and involved in the research
process, and the emergency care context was felt to be acceptable. Participants reported a ‘need to know’
about risks from alcohol consumption, as this behaviour was seen to be common among young people.
However, the presence of a primary caregiver during screening procedures could influence a young
person’s disclosure about alcohol use. The majority of participants demonstrated a high degree of moral
agency, that is, an awareness and capacity to be responsible for actions related to their own health and
well-being, and this extended to providing consent, on their own behalf, to participate in the relevant
clinical trial.
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Conclusions
There is limited evidence regarding effective behaviour change interventions for young people attending
health services owing to concerns about involving vulnerable adolescents in research. However, even
relatively young adolescents reported the capacity to provide informed consent and showed a clear interest
in research that was relevant to them and had potential to benefit young people like them.
Discussion
The results of both the low- and the high-risk trials showed that we were able to recruit a sufficient
number of participants to each trial to meet our target. We were also able to exceed the minimum follow-up
targets in both trials. However, in both trials no significant differences in outcome were found between
groups on either primary or secondary outcome measures. This supported the null hypothesis that PFBA
and eBI are no more effective in preventing or reducing alcohol consumption in either low- or high-risk
drinkers than screening alone.
In both trials, we found that engagement with the eBI was low among participants randomised to eBI.
Only one-third of participants engaged with the eBI platform after leaving the ED. This may have limited
the impact of the eBI compared with the control intervention. However, as these were pragmatic trials, this
is likely to be the level of engagement expected in the typical patient recruited from an ED.
Low application program (app) usage or engagement is a common issue. The vast majority of apps, and
other online interventions, are not used 1 month after they are downloaded. We also know that patients
are less likely to engage in extended interventions when the onus to engage is on them.
A large proportion of the literature based on eBI has focused on the provision of websites, as opposed to
smartphone apps. Arguably, the most important problem with developing an effective eBI app is engaging
participants enough for them to find it useful.
Further research should explore strategies to improve engagement with the intervention.
Patient and public involvement
We worked closely with the British Youth Council and the Family and Parenting Institute, which facilitated
focus group workshops in London and Newcastle. About 150 members of our target age group
contributed to both methodology and materials. This activity changed our screening and intervention,
notably the use of tablet computers for consent and data collection, and the design of specific materials,
notably our PFBA brief advice leaflet and SIPS City app (version 2.1, King’s College London, London, UK).
We now maintain a database of young people interested in taking this work forward, whom we intend to
engage in disseminating study findings.
Overall conclusions
This research programme was designed to address key gaps in the evidence base for the most clinically
effective and cost-effective SBIs for adolescents attending EDs. The research has advanced our understanding
of the nature and prevalence of AUDs in adolescents, and provided a firm foundation for future research to
improve care for this population. We established the prevalence of AUDs and consequences of drinking in
young people attending EDs using validated research tools. We developed age-appropriate and acceptable
interventions for this population, in partnerships with national and local organisations, and tested them in
two linked randomised trials.
DOI: 10.3310/pgfar08020 PROGRAMME GRANTS FOR APPLIED RESEARCH 2020 VOL. 8 NO. 2
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Deluca et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii
Trial registration
This trial is registered as ISRCTN45300218.
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This project was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied
Research programme and will be published in full in Programme Grants for Applied Research; Vol. 8, No. 2.
See the NIHR Journals Library website for further project information.
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The excessive consumption of alcohol is a major global public health issue,1 and, in Europe, alcohol
accounted for 6.5% of deaths and 11.6% of disability-adjusted life-years in 2004.2 Although the main
burden of chronic alcohol-related disease is in adults, its foundations often lie in adolescence.3 The
proportion of young people in England aged between 11 and 15 years who reported that they had drunk
alcohol decreased from 62% to 54% between 1988 and 2007, but the mean amount consumed by those
who drank doubled (from 6.4 to 12.7 units of alcohol per week) between 1994 and 2007.4 About 10% of
11- to 15-year-olds and 33% of 15- to 16-year-olds in England report alcohol intoxication in the past
month.5,6 Adolescents in the UK are now among the heaviest drinkers in Europe.6 The Chief Medical
Officer for England provided recommendations on alcohol consumption in young people in 2009,7 based
on an evidence review.8 These advise that children abstain from alcohol before the age of 15 years and
that 15- to 17-year-olds should not drink, but, if they do drink, then they should consume no more than
the recommended limits for adults (currently 14 units per week).7
Alcohol consumption and related harm increase steeply from the age of 12 to 20 years.9 In early
adolescence, alcohol use and alcohol use disorders (AUDs) (alcohol abuse, harmful alcohol use and alcohol
dependence) are relatively uncommon. However, alcohol has a disproportionate effect on younger
adolescents, for example by predisposing them to alcohol dependence in later life10,11 and damage to the
developing brain.12 In middle adolescence (ages 15–17 years), binge drinking emerges. Although binge
drinking does not necessarily meet the criteria for AUDs, it is associated with increased risk of unprotected
or regretted sexual activity, criminal and disorderly behaviour, suicidality and self-harm, injury, drink driving,
alcohol poisoning and accidental death.6,13–16
Alcohol screening
Opportunistic alcohol screening and brief interventions (SBIs) in emergency departments (EDs) capitalise
on the ‘teachable moment’ when a connection can be made between alcohol consumption and ED
attendance.17–20 Alcohol SBI in EDs has shown efficacy in adults20 and adolescents,17,18,21 with evidence
of cost-effectiveness in adults.22 Over the past 15 years, the World Health Organization, the US Surgeon
General, the American Medical Association and the American Academy of Pediatrics have called for
practitioners to carry out SBIs for adolescent drinkers.23–26 The alcohol strategies for both England and
Scotland identify adolescents as a key target group in which to reduce alcohol consumption and related
harm.27,28 However, although there has been an increase in alcohol SBIs for adults, adolescents remain a
neglected group. A recent audit of EDs in Scotland found that only 5% of alcohol-related attenders aged
< 18 years receive an alcohol intervention before discharge, and that ED staff focus more on those young
people presenting with acute intoxication or self-harm.29 Of the 12 EDs in the north-east of England and
London approached during our research programme, none used routine alcohol screening in 10- to
17-year-olds and only three did so in adults.
Several alcohol screening methods have been developed in the USA but have not been evaluated in the UK.
A recent systematic review of alcohol SBIs in young people (aged 10–17 years) and adults (aged ≥ 18 years),
conducted for the National Institute for Health and Care Excellence (NICE),30 examined 51 studies of alcohol
screening. Questionnaires were found to perform better than blood markers or breath alcohol concentration
in all age groups. In adolescents ,the Alcohol Use Disorders Identification Test (AUDIT) questionnaire was
found to have greater sensitivity and specificity than other questionnaires, including CAGE (Cut Down,
Annoyed, Guilty, Eye Opener), TWEAK (Tolerance, Worried, Eye-opener, Amnesia, K/Cut Down),
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CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble), RAPS4-QF (Rapid Alcohol Problems Screen – Quantity
Frequency), FAST (Fast Alcohol Screening Test), RUFT (Cut-Riding, Unable, Family/Friends, Trouble, Cut down)
and POSIT (Problem Oriented Screening Instrument for Teenagers). AUDIT sensitivities for adolescents range
from 54% to 87% and specificities range from 65% to 97%.31 However, the majority were at the lower
end of these ranges and are therefore suboptimal for effective screening.
Additional shortcomings of existing alcohol screening methods for adolescents have been identified.31
Existing approaches do not sufficiently take into account the age and developmental stage of adolescents.
Any alcohol consumption under 15 years of age is of concern, whereas the identification of AUDs is more
relevant in older adolescents. There is therefore a need for screening methods that are sensitive to the
developmental stage of the adolescent to maximise opportunities for intervention. Alcohol screening has
been mostly studied in older adolescents and young adults of college age (18–24 years). Therefore, the
validity of alcohol screening methods in younger adolescents is unclear. Questionnaires such as the AUDIT
may be too lengthy (10 items) to implement in busy EDs, pointing to the need for briefer tools for routine
clinical practice. Methods to increase compliance, particularly by younger adolescents, are also needed.
The use of computer screening and interviewing adolescents confidentially and separately from parents has
shown some promise in the USA.32,33
Alcohol brief interventions in health settings
Several systematic reviews have noted the effectiveness of SBIs in adults in health settings.34–38 Less research
in this area has been conducted in adolescents. A systematic review of brief alcohol interventions for
young people attending health settings identified nine randomised controlled trials (RCTs) between 1999
and 2008.30 Eight were based in the USA17–19,21,39–41 and one was based in Australia.42 Most trials were
considered to be methodologically sound, although two were considered to be weak in randomisation
and allocation concealment.40,42 Sample sizes ranged from 34 to 655 and ages ranged from 12 to 24 years.
Three trials40–42 targeted socioeconomically disadvantaged groups among whom drug and alcohol misuse
were more prevalent. Four trials17–19,21 were based in EDs to maximise the potential for ‘teachable moments’
when the connection between alcohol consumption and its adverse consequences can be more readily
highlighted. Two studies39,40 recruited adolescents during routine general check-ups in primary care and one43
recruited in a university health centre. The remaining trials targeted homeless adolescents41 and those
attending a youth centre that delivered health services.42
Six trials17,18,21,40,41,43 tested brief interventions based on one or two sessions of motivational interviewing
(MI) that lasted between 20 and 45 minutes. Delivery was carried out by a range of trained professionals,
including physicians, nurse practitioners, psychologists, addiction clinicians and youth workers. One trial
tested a more intensive programme of four MI sessions over 1 month.42 Two studies used information
technology to deliver brief interventions, one using an audio programme in primary care39 and the other
using an interactive computer program in a minor injury unit.19 The length of follow-up ranged from 2 to
12 months. Loss to follow-up was generally low (0–20%), although the authors of one study40 reported
that 34% of their study population were lost to follow-up.
Five trials17,18,21,42,43 reported significant positive effects of brief interventions on a range of alcohol consumption
measures. Bailey et al.42 reported that brief intervention participants showed increased readiness to reduce
alcohol consumption, an initial reduction in alcohol consumption and an improvement in knowledge of alcohol
and related problems, compared with control subjects. Schaus et al.43 also reported reductions in blood
alcohol concentration, number of drinks per week and risk-taking behaviour. Monti et al.18 reported
that brief intervention subjects were less likely than control subjects to drink and drive or to experience
alcohol-related injury, although both treatment groups significantly reduced their alcohol consumption.
A subsequent trial, conducted by the same research group,17 reported that alcohol consumption also
significantly decreased in both the brief intervention group and the control group. Last, Spirito et al.21
reported a significant reduction in alcohol consumption at follow-up in both the brief intervention group
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and the control group. However, adolescents who screened positive for alcohol problems at baseline
reported more change after MI than the control subjects.
Three trials reported null effects after brief intervention.19,40,41 One trial that used an audio-taped
programme with 12- to 17-year-old adolescents39 reported an increase in alcohol use and binge drinking
among brief intervention subjects, representing a possible adverse effect of this type of intervention.
Summary
In summary, there is a need to develop more effective alcohol screening tools for adolescents in the ED,
which are age appropriate and cover a wider range of alcohol consumption and alcohol-related problems
than do existing methods. Furthermore, as most of the existing research has been conducted in the USA,
screening methods appropriate to EDs are needed in the UK context of the NHS.
Moreover, the majority of alcohol SBI studies among adolescents in health-care settings were conducted
in EDs and reported positive outcomes. However, three trials reported alcohol consumption reductions
in both the intervention group and the control group, and three more trials reported no effect of brief
intervention. None of these trials was in the UK and few studies were conducted in young adolescents.
Thus, although there is evidence to suggest that brief intervention may be beneficial for adolescents,
particularly in EDs, there is a clear need for a UK trial of this.
This monograph describes the results of our findings linked to the original programme objectives (a full list
of publications arising from our programme of work can be found in Overall conclusions, Dissemination).
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